Rimoldi D - Search Results

1

Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.

Rimoldi D, Lemoine R, Kurt AM, Salvi S, Berset M, Matter M, Roche B, Cerottini JP, Guggisberg D, Krischer J, Braun R, Willi JP, Antonescu C, Slosman D, Lejeune FJ, Liénard D; Groupe Mélanome Lémanique. Rimoldi D, et al. Melanoma Res. 2003 Oct;13(5):511-20. doi: 10.1097/00008390-200310000-00010. Melanoma Res. 2003. PMID: 14512793

2

Lack of BRAF mutations in uveal melanoma.

Rimoldi D, Salvi S, Liénard D, Lejeune FJ, Speiser D, Zografos L, Cerottini JC. Rimoldi D, et al. Cancer Res. 2003 Sep 15;63(18):5712-5. Cancer Res. 2003. PMID: 14522889

3

Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.

Hartmann RR, Rimoldi D, Lejeune FJ, Carrel S. Hartmann RR, et al. Among authors: rimoldi d. Melanoma Res. 1997 Aug;7 Suppl 2:S27-33. Melanoma Res. 1997. PMID: 9578414

4

Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.

Berset M, Cerottini JP, Guggisberg D, Romero P, Burri F, Rimoldi D, Panizzon RG. Berset M, et al. Among authors: rimoldi d. Int J Cancer. 2001 Jan 20;95(1):73-7. doi: 10.1002/1097-0215(20010120)95:1<73::aid-ijc1013>3.0.co;2-s. Int J Cancer. 2001. PMID: 11241315

5

Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma.

Willi JP, Matter M, Buchegger F, Antonescu C, Guggisberg D, Cerottini JP, Krischer J, Braun R, Marie Kurt A, Roche B, Lemoine R, Rimoldi D, Lejeune FJ, Liénard D, Bischof Delaloye A. Willi JP, et al. Among authors: rimoldi d. Nuklearmedizin. 2007;46(6):244-51. Nuklearmedizin. 2007. PMID: 18084679 Free article.

6

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Liénard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A, Rufer N, Lubenow N, Speiser D, Cerottini JC, Romero P, Pittet MJ. Zippelius A, et al. Among authors: rimoldi d. Cancer Res. 2004 Apr 15;64(8):2865-73. doi: 10.1158/0008-5472.can-03-3066. Cancer Res. 2004. PMID: 15087405

7

New approaches in metastatic melanoma: biological and molecular targeted therapies.

Lejeune FJ, Rimoldi D, Speiser D. Lejeune FJ, et al. Among authors: rimoldi d. Expert Rev Anticancer Ther. 2007 May;7(5):701-13. doi: 10.1586/14737140.7.5.701. Expert Rev Anticancer Ther. 2007. PMID: 17492933 Review.

8

Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.

Ayyoub M, Zippelius A, Pittet MJ, Rimoldi D, Valmori D, Cerottini JC, Romero P, Lejeune F, Liénard D, Speiser DE. Ayyoub M, et al. Among authors: rimoldi d. Clin Cancer Res. 2003 Feb;9(2):669-77. Clin Cancer Res. 2003. PMID: 12576434

9

Disease-driven T cell activation predicts immune responses to vaccination against melanoma.

Speiser DE, Rimoldi D, Batard P, Liénard D, Lejeune F, Cerottini JC, Romero P. Speiser DE, et al. Among authors: rimoldi d. Cancer Immun. 2003 Sep 9;3:12. Cancer Immun. 2003. PMID: 12962476

10

Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.

Valmori D, Dutoit V, Ayyoub M, Rimoldi D, Guillaume P, Liénard D, Lejeune F, Cerottini JC, Romero P, Speiser DE. Valmori D, et al. Among authors: rimoldi d. Cancer Immun. 2003 Oct 28;3:15. Cancer Immun. 2003. PMID: 14580186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters